Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Vitamin D supplementation boosts insulin sensitivity

Patients given vitamin D showed increased insulin sensitivity over six months, compared with placebo, leading researchers to call for larger, longer term randomised controlled trials.

Vitamin D supplementation increases peripheral insulin sensitivity in people newly diagnosed with or at high risk of type 2 diabetes mellitus, study results published in the European Journal of Endocrinology have shown (1 July 2019)[1].

The trial included 96 people with high risk of diabetes, or who had early diabetes but were not taking diabetes medication, who were randomly assigned to receive either 5,000 IU of vitamin D3 daily or placebo for six months. Peripheral insulin sensitivity was measured at baseline and six months using a two-hour hyperinsulinaemic-euglycemic clamp and expressed as an M-value.

The results showed that, while the M-value remained constant in the control group during this time, it increased by a mean of 23% in the intervention group, indicating increased insulin sensitivity (mean change: –0.03 vs. +0.92, respectively).

Low vitamin D status is associated with an increased risk of developing diabetes, the researchers explained. However, randomised controlled trials (RCTs) of vitamin D as an intervention to improve insulin sensitivity have provided inconsistent results.

“Larger and longer term RCTs are required to evaluate whether subgroups of patients, including those with low vitamin D status, may benefit from vitamin D supplementation,” the paper concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207124

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.